New Delhi: The Oxford COVID-19 vaccine manufactured by the Serum Institute of India will be sent for approval to the regulator Drugs Controller General of India (DCGI) by a government-appointed panel of experts.
The Serum Institute of India (SII) is making the vaccine Covishield developed by Oxford University and pharma major AstraZeneca, while Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) for its Covaxin.
Pfizer had sought more time to present their data to the panel of experts.
The centre is looking to start giving vaccine shots from this month, once the vaccine is cleared for a final time by the DCGI.
Meanwhile, the World Health Organization on Thursday granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution.
.
Here are the Highlights on Coronavirus Cases:
Jan 01, 2021 23:39 (IST)
Coronavirus LIVE Updates: Karnataka reports 877 new COVID-19 cases, 6 deaths
Karnataka on Friday reported 877 new cases of COVID-19 and six related fatalities, taking the total number of infections to 9,20,373 and the death count to 12,096, PTI reported.
Jan 01, 2021 21:08 (IST)
Coronavirus LIVE Updates: BioNTech founders warn of vaccine supply gaps
BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.
The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union because of relatively late approval from the bloc's health regulator and the small size of the order placed by Brussels.
The delays in rolling out the home-grown vaccine have caused consternation in Germany, where some regions had to halt vaccinations within days of starting an inoculation drive, Reuters reported.
Jan 01, 2021 20:55 (IST)
Coronavirus LIVE Updates: 32 new COVID-19 cases, recovery rate over 98% in Noida
The recovery rate of COVID-19 patients went past 98 per cent in Uttar Pradesh's Gautam Buddh Nagar on Friday, even as the district recorded 32 new cases that pushed its inflection tally to 24,974, PTI reported.